CORP — CORPORATE / INDUSTRY

Alnylam Investigator-Initiated Studies & Grants

Alnylam Pharmaceuticals

Award

IIS funding/drug; educational grants

Deadline

IIS rolling; advocacy grants no longer listed

Award type

Cash grant

Focus

Org capacity · Clinical research

The investigator-initiated studies program supports research in Alnylam's areas — ATTR amyloidosis, acute hepatic porphyria, and PH1 — with funding and drug, through the SteepRock platform. The Advocacy for Impact grants formerly offered to patient advocacy groups are no longer listed, with no cycle announced since about 2020; the grants and giving page now covers educational grants, sponsorships, and fellowships.

Why it's in this index

No BTHS-adjacent therapeutic area, so the realistic route is educational grants or sponsorships rather than the ISR program.

Who can apply

Advocacy grants: patient advocacy organizations. IIS: physicians, pharmacists, and researchers qualified by training.

How to apply

IIS proposals via the SteepRock platform; educational grant requests through the grants-and-giving page.

Links & downloads

Grants & giving ↗Alnylam IIS ↗